# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-178964
Filing Date
2025-08-12
Accepted
2025-08-12 16:17:17
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktx-20250630.htm iXBRL | 10-Q | 2547771
2 | EX-10.1 | nktx-ex10_1.htm | EX-10.1 | 31838
3 | EX-31.1 | nktx-ex31_1.htm | EX-31.1 | 18072
4 | EX-31.2 | nktx-ex31_2.htm | EX-31.2 | 17559
5 | EX-32 | nktx-ex32.htm | EX-32 | 16984
6 | GRAPHIC | img34246019_0.jpg | GRAPHIC | 121976
| Complete submission text file | 0001193125-25-178964.txt |  | 9383348

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nktx-20250630.xsd | EX-101.SCH | 1063601
67 | EXTRACTED XBRL INSTANCE DOCUMENT | nktx-20250630_htm.xml | XML | 1739895

Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 251206965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)